Stereotactic radiosurgery for patients with solid brain metastases: current status

被引:11
作者
Warnick, RE
Darakchiev, BJ
Breneman, JC
机构
[1] Univ Cincinnati, Coll Med, Inst Neurosci, Dept Neurosurg, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Inst Neurosci, Dept Radiol,Radiat Oncol Div, Cincinnati, OH 45267 USA
[3] Mayfield Clin, REW, Cincinnati, OH USA
关键词
brain metastases; complications; stereotactic radiosurgery; surgery; whole brain radiotherapy;
D O I
10.1023/B:NEON.0000041876.90641.96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The goal of this article is to provide a contemporary update on the use of stereotactic radiosurgery (SRS) for the treatment of intracranial metastatic disease. We discuss the rationale for employing SRS in brain metastases and describe the critical factors that predict outcome. We highlight the main clinical indications for SRS including treatment of recurrent brain metastases after previous whole brain radiation therapy (WBRT), as a boost after WBRT, and as sole therapy for newly diagnosed tumors. For each clinical scenario, we offer a treatment algorithm based on our clinical experience. The article also addresses the most common complications associated with SRS and their treatment.
引用
收藏
页码:125 / 137
页数:13
相关论文
共 53 条
[1]   A phase II trial of temozolomide for patients with recurrent or progressive brain metastases [J].
Abrey, LE ;
Olson, JD ;
Raizer, JJ ;
Mack, M ;
Rodavitch, A ;
Boutros, DY ;
Malkin, MG .
JOURNAL OF NEURO-ONCOLOGY, 2001, 53 (03) :259-265
[2]   STEREOTAXIC RADIOSURGERY FOR THE DEFINITIVE, NONINVASIVE TREATMENT OF BRAIN METASTASES [J].
ALEXANDER, E ;
MORIARTY, TM ;
DAVIS, RB ;
WEN, PY ;
FINE, HA ;
BLACK, PM ;
KOOY, HM ;
LOEFFLER, JS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (01) :34-40
[3]   Phase II Randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases [J].
Antonadou, D ;
Paraskevaidis, M ;
Sarris, G ;
Coliarakis, N ;
Economou, I ;
Karageorgis, P ;
Throuvalas, N .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3644-3650
[4]   A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis [J].
Auchter, RM ;
Lamond, JP ;
Alexander, E ;
Buatti, JM ;
Chappell, R ;
Friedman, WA ;
Kinsella, TJ ;
Levin, AB ;
Noyes, WR ;
Schultz, CJ ;
Loeffler, JS ;
Mehta, MP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (01) :27-35
[5]   Surgery versus radiosurgery in the treatment of brain metastasis [J].
Bindal, AK ;
Bindal, RK ;
Hess, KR ;
Shiu, A ;
Hassenbusch, SJ ;
Shi, WM ;
Sawaya, R .
JOURNAL OF NEUROSURGERY, 1996, 84 (05) :748-754
[6]  
Breneman JC, 1997, CANCER, V79, P551, DOI 10.1002/(SICI)1097-0142(19970201)79:3<551::AID-CNCR18>3.0.CO
[7]  
2-2
[8]  
Brown PD, 2002, NEUROSURGERY, V51, P656, DOI 10.1227/01.NEU.0000023713.44940.20
[9]   Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases [J].
Christodoulou, C ;
Bafaloukos, D ;
Kosmidis, P ;
Samantas, E ;
Bamias, A ;
Papakostas, P ;
Karabelis, A ;
Bacoyiannis, C ;
Skarlos, DV .
ANNALS OF ONCOLOGY, 2001, 12 (02) :249-254
[10]  
DARDOUFAS C, 2001, P AN M AM SOC CLIN, V20, pB75